Study reveals cardiovascular health could be biggest risk factor for dementia
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Read More
Author: Jen Brogan
Study finds headache drug could prevent overuse of acute migraine medications
Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally
Read More
Researchers find whole genome sequencing improves care for paediatric cancer
Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children
Read More
Female cancer survivors at low risk of developing obstetric complications
According to WHO, around 15% of pregnant women will develop an obstetric complication
Read More
University of Liverpool launches new biotech spin-out company Galytx
The biotech company will develop novel therapeutic drugs for the treatment of fatal diseases
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
